China Pharma Holdings
CPHI
6 hedge funds and large institutions have $77K invested in China Pharma Holdings in 2022 Q3 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 3 closing their positions.
0% less ownership
Funds ownership: 0% → 0% (-0%)
25% less funds holding
Funds holding: 8 → 6 (-2)
52% less capital invested
Capital invested by funds: $159K → $77K (-$82K)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
Top Buyers
| 1 |
Renaissance Technologies
New York
|
+$8.98K |
| 2 |
TSS
Two Sigma Securities
New York
|
+$4.04K |
Top Sellers
| 1 |
VF
Virtu Financial
New York
|
-$19K |
| 2 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$9.86K |
| 3 |
Millennium Management
New York
|
-$7.99K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$7K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Renaissance Technologies
New York
| $47K | +$8.98K | +91 | +14% |
|
|
BCM
2
Bridgeway Capital Management
Houston,
Texas
| $19K | -$9.86K | -100 | -26% |
|
|
3
Millennium Management
New York
| $4K | -$7.99K | -81 | -57% |
|
4
Two Sigma Advisers
New York
| $3K | -$99 | -1 | -2% |
|
|
TSS
5
Two Sigma Securities
New York
| $3K | +$4.04K | +41 | New |
|
|
FCT
6
First Community Trust
Dubuque,
Iowa
| $1K | – | – | – |
|
|
VF
7
Virtu Financial
New York
| – | -$19K | -177 | Closed |
|
|
8
Citadel Advisors
Miami,
Florida
| – | -$7K | -70 | Closed |
|
|
9
UBS Group
Zurich,
Switzerland
| – | -$3K | -25 | Closed |
|
CPHI Hedge Fund Activity: Q3 2022 in Review
6 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in China Pharma Holdings (CPHI) for Q3 2022, worth a combined $77K — down 52% from $159K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of CPHI and 1 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 1 added.
The largest buyer was Renaissance Technologies, adding an estimated $8.98K. The largest seller was Virtu Financial, exiting entirely with an estimated $19K sold.
- 6 institutional investors held China Pharma Holdings (CPHI) as of Q3 2022, down from 8 in Q2 2022.
- Funds reported $77K of China Pharma Holdings stock for Q3 2022, down 52% quarter-over-quarter.
- 1 fund opened new China Pharma Holdings positions in Q3 2022 and 3 closed out, a net change of -2 holders.
- The largest China Pharma Holdings buyer in Q3 2022 was Renaissance Technologies, an estimated $8.98K added.
- The largest China Pharma Holdings seller in Q3 2022 was Virtu Financial, an estimated $19K sold.
Based on aggregated 13F filings for Q3 2022.